Medpace Holdings (MEDP) FCF Margin (2015 - 2026)
Medpace Holdings' (MEDP) quarterly FCF Margin came in at 19.52% in Q2 2026, down 408.0% on a YoY basis from 6.34% in Q2 2025, and down 4.84% quarter-over-quarter from 20.52% in Q1 2026.
Powered by 
Analysis
Medpace Holdings (MEDP) FCF Margin (2015 - 2026) Analysis & Trends
Medpace Holdings (MEDP) has reported FCF Margin for 12 consecutive years, with 19.52% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, FCF Margin fell 408.0% year-over-year to 19.52%; the trailing twelve-month figure through Jun 2026 stood at 25.4% (down 58.0% YoY), and the FY2025 full-year result was 26.95%, down 19.0% from the prior year.
- FCF Margin retreated to 19.52% in Q2 2026 per MEDP's latest filing, from 20.52% in the prior quarter.
- Across five years, FCF Margin topped out at 35.69% in Q3 2025 and bottomed at 11.18% in Q1 2022.
- Historically, FCF Margin has averaged 24.03% across 5 years, with a median of 23.96% in 2022.
- The sharpest annual moves came in 2022 and 2024: FCF Margin sank 837 bps in 2022, then surged 1254 bps in 2024.
- Over 5 years, FCF Margin stood at 32.34% in 2022, then declined by 9 bps to 29.38% in 2023, then gained by 16 bps to 34.11% in 2024, then dropped by 22 bps to 26.55% in 2025, then declined by 26 bps to 19.52% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 19.52%, 20.52%, and 26.55% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 8.24% |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 19.52% |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 15.69% |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 14.80% |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 2.93% |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -232.65% |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -4.05% |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -103.39% |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -17,977.78% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.52% |
| Mar 31, 2026 | 20.52% |
| Dec 31, 2025 | 26.55% |
| Sep 30, 2025 | 35.69% |
| Jun 30, 2025 | 23.61% |
| Mar 31, 2025 | 20.74% |
| Dec 31, 2024 | 34.11% |
| Sep 30, 2024 | 25.98% |
| Jun 30, 2024 | 19.60% |
| Mar 31, 2024 | 28.80% |
| Dec 31, 2023 | 29.38% |
| Sep 30, 2023 | 21.46% |
| Jun 30, 2023 | 16.07% |
| Mar 31, 2023 | 16.26% |
| Dec 31, 2022 | 32.34% |
| Sep 30, 2022 | 26.40% |
| Jun 30, 2022 | 24.32% |
| Mar 31, 2022 | 11.18% |
| Dec 31, 2021 | 20.02% |
| Sep 30, 2021 | 22.23% |